1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies

Bibliographic Details
Main Authors: Ankita Srivastava, Arvin Akoopie, Ranveer Jayani, Jonah Rainey, Tracy Charlton, Omer Keinan, Jacek Ostrowski
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797629814937485312
author Ankita Srivastava
Arvin Akoopie
Ranveer Jayani
Jonah Rainey
Tracy Charlton
Omer Keinan
Jacek Ostrowski
author_facet Ankita Srivastava
Arvin Akoopie
Ranveer Jayani
Jonah Rainey
Tracy Charlton
Omer Keinan
Jacek Ostrowski
author_sort Ankita Srivastava
collection DOAJ
first_indexed 2024-03-11T10:59:19Z
format Article
id doaj.art-8d268105a3294942a9831aee83e63bf2
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T10:59:19Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-8d268105a3294942a9831aee83e63bf22023-11-12T20:25:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11861186 Engineering bispecific dual-antagonist antibodies for novel cancer therapiesAnkita Srivastava0Arvin Akoopie1Ranveer Jayani2Jonah Rainey3Tracy Charlton4Omer Keinan5Jacek Ostrowski6Dermatology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India1AlivaMab Discovery Services, San Diego, CA, USA1AlivaMab Discovery Services, San Diego, CA, USA2Eli Lilly, Lilly Biotechnology Center, San Diego, CA, USA1AlivaMab Discovery Services, San Diego, CA, USA1AlivaMab Discovery Services, San Diego, CA, USA3Avidity Biosciences, San Diego, CA, USA
spellingShingle Ankita Srivastava
Arvin Akoopie
Ranveer Jayani
Jonah Rainey
Tracy Charlton
Omer Keinan
Jacek Ostrowski
1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
Journal for ImmunoTherapy of Cancer
title 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
title_full 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
title_fullStr 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
title_full_unstemmed 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
title_short 1186 Engineering bispecific dual-antagonist antibodies for novel cancer therapies
title_sort 1186 engineering bispecific dual antagonist antibodies for novel cancer therapies
work_keys_str_mv AT ankitasrivastava 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies
AT arvinakoopie 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies
AT ranveerjayani 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies
AT jonahrainey 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies
AT tracycharlton 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies
AT omerkeinan 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies
AT jacekostrowski 1186engineeringbispecificdualantagonistantibodiesfornovelcancertherapies